Headquartered in Metamorfosi with >350 employees, PharOS is a Greek pharmaceutical leader producing 100+ generic and specialty medicines across oncology, neurology, and cardiometabolic therapies. With >9,200+ global marketing authorizations, the company delivers wide-reaching therapeutic solutions.

‍

As a resilience backbone of our portfolio, PharOS advances our health and well-being focus through scalable innovations that broaden medicine access while strengthening health system foundations worldwide.